Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Racial disparities in molecular subtypes of endometrial cancer.

Dubil EA, Tian C, Wang G, Tarney CM, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM.

Gynecol Oncol. 2018 Apr;149(1):106-116. doi: 10.1016/j.ygyno.2017.12.009.

PMID:
29605044
2.

Recent advances and opportunities in proteomic analyses of tumour heterogeneity.

Bateman NW, Conrads TP.

J Pathol. 2018 Apr;244(5):628-637. doi: 10.1002/path.5036. Epub 2018 Feb 14. Review.

PMID:
29344964
3.

Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma.

Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, Bateman NW, Conrads TP, Hamilton CA, Larry Maxwell G, Darcy KM.

Int J Gynecol Cancer. 2018 Feb;28(2):338-345. doi: 10.1097/IGC.0000000000001156.

PMID:
29232272
4.

Impact of age at diagnosis on racial disparities in endometrial cancer patients.

Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM.

Gynecol Oncol. 2018 Apr;149(1):12-21. doi: 10.1016/j.ygyno.2017.07.145. Epub 2017 Aug 8.

PMID:
28800945
5.

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.

Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, Shriver CD, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL.

Cancer. 2017 Oct 15;123(20):4004-4012. doi: 10.1002/cncr.30813. Epub 2017 Jun 27.

6.

Quantitative Mass Spectrometry by Isotope Dilution and Multiple Reaction Monitoring (MRM).

Russo P, Hood BL, Bateman NW, Conrads TP.

Methods Mol Biol. 2017;1606:313-332. doi: 10.1007/978-1-4939-6990-6_20.

PMID:
28502009
7.

Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.

Teng PN, Bateman NW, Wang G, Litzi T, Blanton BE, Hood BL, Conrads KA, Ao W, Oliver KE, Darcy KM, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Conrads TP.

Hum Cell. 2017 Jul;30(3):226-236. doi: 10.1007/s13577-017-0162-1. Epub 2017 Mar 1.

PMID:
28251557
8.

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer.

Phippen NT, Bateman NW, Wang G, Conrads KA, Ao W, Teng PN, Litzi TA, Oliver J, Maxwell GL, Hamilton CA, Darcy KM, Conrads TP.

Front Oncol. 2016 Oct 27;6:213. eCollection 2016.

9.

Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A.

Bateman NW, Shoji Y, Conrads KA, Stroop KD, Hamilton CA, Darcy KM, Maxwell GL, Risinger JI, Conrads TP.

Biochem Biophys Res Commun. 2016 Jan 1;469(1):114-119. doi: 10.1016/j.bbrc.2015.11.080. Epub 2015 Nov 22.

PMID:
26614907
10.

Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.

Bateman NW, Jaworski E, Ao W, Wang G, Litzi T, Dubil E, Marcus C, Conrads KA, Teng PN, Hood BL, Phippen NT, Vasicek LA, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP.

J Proteome Res. 2015 Apr 3;14(4):1900-10. doi: 10.1021/pr5012894. Epub 2015 Mar 19.

11.

Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle.

Hood BL, Liu B, Alkhas A, Shoji Y, Challa R, Wang G, Ferguson S, Oliver J, Mitchell D, Bateman NW, Zahn CM, Hamilton CA, Payson M, Lessey B, Fazleabas AT, Maxwell GL, Conrads TP, Risinger JI.

Biol Reprod. 2015 Apr;92(4):106. doi: 10.1095/biolreprod.114.127217. Epub 2015 Feb 18.

PMID:
25695723
12.

Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Teng PN, Bateman NW, Darcy KM, Hamilton CA, Maxwell GL, Bakkenist CJ, Conrads TP.

Gynecol Oncol. 2015 Mar;136(3):554-61. doi: 10.1016/j.ygyno.2014.12.035. Epub 2015 Jan 2.

13.

Maximizing peptide identification events in proteomic workflows using data-dependent acquisition (DDA).

Bateman NW, Goulding SP, Shulman NJ, Gadok AK, Szumlinski KK, MacCoss MJ, Wu CC.

Mol Cell Proteomics. 2014 Jan;13(1):329-38. doi: 10.1074/mcp.M112.026500. Epub 2013 Jul 2.

14.

Multiplexed MS/MS for improved data-independent acquisition.

Egertson JD, Kuehn A, Merrihew GE, Bateman NW, MacLean BX, Ting YS, Canterbury JD, Marsh DM, Kellmann M, Zabrouskov V, Wu CC, MacCoss MJ.

Nat Methods. 2013 Aug;10(8):744-6. doi: 10.1038/nmeth.2528. Epub 2013 Jun 23.

15.

Mitochondrial respiration--an important therapeutic target in melanoma.

Barbi de Moura M, Vincent G, Fayewicz SL, Bateman NW, Hood BL, Sun M, Suhan J, Duensing S, Yin Y, Sander C, Kirkwood JM, Becker D, Conrads TP, Van Houten B, Moschos SJ.

PLoS One. 2012;7(8):e40690. doi: 10.1371/journal.pone.0040690. Epub 2012 Aug 17.

16.

Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.

Zhao T, Zeng X, Bateman NW, Sun M, Teng PN, Bigbee WL, Dhir R, Nelson JB, Conrads TP, Hood BL.

J Proteome Res. 2012 Feb 3;11(2):1089-99. doi: 10.1021/pr200829f. Epub 2011 Dec 1.

PMID:
22077639
17.

Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.

Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J, Miller C, Sun M, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, Parwani A, Sandburg G, Rose S, Becich MJ, Berchuck A, Kohn E, Risinger JI, Conrads TP.

Gynecol Oncol. 2011 Jun 1;121(3):586-94. doi: 10.1016/j.ygyno.2011.02.031. Epub 2011 Apr 1.

PMID:
21458040
18.

Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues.

Bateman NW, Sun M, Bhargava R, Hood BL, Darfler MM, Kovatich AJ, Hooke JA, Krizman DB, Conrads TP.

J Proteome Res. 2011 Mar 4;10(3):1323-32. doi: 10.1021/pr101073s. Epub 2011 Jan 19.

PMID:
21155598
19.

Advances in proximal fluid proteomics for disease biomarker discovery.

Teng PN, Bateman NW, Hood BL, Conrads TP.

J Proteome Res. 2010 Dec 3;9(12):6091-100. doi: 10.1021/pr100904q. Epub 2010 Nov 11. Review.

PMID:
21028795
20.

Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation.

Lu X, Beck GR Jr, Gilbert LC, Camalier CE, Bateman NW, Hood BL, Conrads TP, Kern MJ, You S, Chen H, Nanes MS.

J Bone Miner Res. 2011 Jan;26(1):209-19. doi: 10.1002/jbmr.203.

21.

Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase.

Bateman NW, Sun M, Hood BL, Flint MS, Conrads TP.

J Proteome Res. 2010 Oct 1;9(10):5311-24. doi: 10.1021/pr100580e.

PMID:
20681588
22.

Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis.

Teng PN, Rungruang BJ, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP.

J Proteome Res. 2010 Aug 6;9(8):4161-9. doi: 10.1021/pr100382v.

PMID:
20518575
23.

Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway.

Flint MS, Kim G, Hood BL, Bateman NW, Stewart NA, Conrads TP.

Psychoneuroendocrinology. 2009 Nov;34(10):1533-41. doi: 10.1016/j.psyneuen.2009.05.008. Epub 2009 Jun 26.

PMID:
19560278
24.

PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.

Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW, Janssen KP, Robine S, Velcich A, Augenlicht LH, Black AR, Black JD.

Exp Cell Res. 2009 May 1;315(8):1415-28. doi: 10.1016/j.yexcr.2009.02.002. Epub 2009 Feb 14.

25.

Large-scale automated analysis of location patterns in randomly tagged 3T3 cells.

García Osuna E, Hua J, Bateman NW, Zhao T, Berget PB, Murphy RF.

Ann Biomed Eng. 2007 Jun;35(6):1081-7. Epub 2007 Feb 7.

26.

Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells.

Frey MR, Clark JA, Bateman NW, Kazanietz MG, Black AR, Black JD.

Biochem Pharmacol. 2004 May 15;67(10):1873-86.

PMID:
15130764
27.

Intestinal tumor progression is associated with altered function of KLF5.

Bateman NW, Tan D, Pestell RG, Black JD, Black AR.

J Biol Chem. 2004 Mar 26;279(13):12093-101. Epub 2004 Jan 15.

Supplemental Content

Loading ...
Support Center